Condition
Sweat Gland Diseases
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (1)
P 2 (3)
Trial Status
Unknown3
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05102396Phase 2Recruiting
Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?
NCT04906655Phase 2Completed
An Open Label Study for Palmar Hyperhydrosis
NCT03426085Phase 2Unknown
The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
NCT01539460Not ApplicableUnknownPrimary
A Minimally Invasive Surgery for Axillary Osmidrosis: Combined Liposuction With Subcutaneous Pruning
NCT02304562Phase 1UnknownPrimary
Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair
Showing all 5 trials